New York Prosecutor Pushes to Criminalize Unlicensed Crypto Operations
A senior New York prosecutor is urging state lawmakers to take a tougher stance on cryptocurrency crime, warning against regulatory gaps. The post New York...
BTC
ETH
USDT
XRP
USDC
SOL
TRX
FIGR_HELOC
DOGE
WBT
USDS
LEO
HYPE
ADA
BTC
ETH
USDT
XRP
USDC
SOL
TRX
FIGR_HELOC
DOGE
WBT
USDS
LEO
HYPE
ADA
BTC
ETH
USDT
XRP
USDC
SOL
TRX
FIGR_HELOC
DOGE
WBT
USDS
LEO
HYPE
ADA
BTC
ETH
USDT
XRP
USDC
SOL
TRX
FIGR_HELOC
DOGE
WBT
USDS
LEO
HYPE
ADA
L1 Capital, an investment management firm, released its "L1 Capital International Fund" (unhedged) fourth-quarter 2025 investor letter. A copy of the lette...
Most popular articles this week
Latest news from global stock markets, tech giants, and financial sectors
Browse ArticlesBitcoin, Ethereum, altcoins, DeFi, NFTs, and blockchain technology
Browse ArticlesGold, silver, oil, natural gas, and other precious commodities
Browse Articles
A senior New York prosecutor is urging state lawmakers to take a tougher stance on cryptocurrency crime, warning against regulatory gaps. The post New York...
US FDA requests removal of suicide warnings from weight-loss drug labels
Tether announced a partnership with the United Nations Office on Drugs and Crime to fund cybersecurity bootcamps in Senegal, trafficking victim assistance...
Novo launches Wegovy weight-loss pill for sale in US
Novo Nordisk's wildly successful obesity medicine is now available as a pill, making it the first GLP-1 pill for weight loss in the U.S.
Weight-loss pill approval set to accelerate food industry product overhauls
Engaging one of the worldâEUR(TM)s most repressive regimes, Trump envoy bonded with Belarusian dictator over Zepbound and obtained the release of hundreds...
A shaky economy, wider adoption of weight-loss drugs, and changing tastes seem to conspire against some food makers.
Stock Market Today: The Dow Jones index and the S&P 500 rise, aided by tech stock. Novo stock soared on FDA approval for a weight-loss pill.
The growing use of weight-loss drugs is one factor behind the decline in alcohol consumption.
Novo Nordisk's weight-loss challenge in five charts
Relief rally underway in Novo Nordisk after a difficult year for the stock which saw it lose ground to arch-competitor Eli Lilly.